Dr. John Wallace | Source | Doctor and Pharma Researcher at Antibe Therapeutics
Dr. John Wallace
John is an Adjunct Professor of Physiology & Pharmacology at the Cumming School of Medicine at the University of Calgary. He holds a PhD in Medical Sciences (University of Toronto), a B.Sc. and an M.Sc. in Biological Sciences (Queen’s University). From 2009 to 2012, John was Founding Director of the Farncombe Family Digestive Health Research Institute at McMaster University. He completed post-doctoral studies at the Wellcome Research Laboratories in London, England, and he holds an MBA from the University of Birmingham, England.
-
Antibe Therapeutics
Doctor and Pharma Researcher
-
Antibe Therapeutics Announces the Formation of Its Clinical Advisory Board
Antibe Therapeutics Inc. (“Antibe” or the “Corporation”) (TSXV:ATE) is pleased to announce the formation of its Clinical Advisory Board with the appoi
Article
-
We are exceptionally pleased and honoured to have these three globally recognized clinical investigators on our Clinical Advisory Board. Drs. Chan, Lanas, and Scheiman have designed and been the chief investigators of large clinical trials in the anti-inflammatory space including those that resulted in the marketing approval of Celebrex, now one of the most widely prescribed arthritis treatment medications.
